More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer. Researchers report they have identified an existing group of drugs that appear to reduce or eliminate a certain subgroup of childhood brain cancers while sparing normal brain tissue. The research was conducted using a new zebrafish animal model system developed by the researchers, which closely resembles an aggressive subtype of pediatric brain tumors.